“Researchers are developing an electronic nose that would sniff out tuberculosis (TB) like a Breathalyzer detects alcohol, putting an end to current time-consuming tests and possibly saving hundreds of thousands of lives each year,” the Globe and Mail reports (D’Aliesio, 11/7). A team of Indian researchers is planning to have a prototype in hospitals by October 2013, after receiving a $950,000 grant on Monday from Grand Challenges Canada and the Bill & Melinda Gates Foundation, according to the Guardian (Tran, 11/7).

“The so-called ‘E-Nose’ is a battery-operated device, similar to an alcohol Breathalyzer, which offers a rapid and accurate diagnosis,” GlobalPost notes (Morrow, 11/7). “It is estimated that up to 400,000 lives a year can be saved in the developing world by early diagnosis, immediate treatment and reduced transmission of TB,” the Guardian writes, adding, “One big advantage of this hand-held, battery-powered device is that testing can be done at village level so people do not have to make the trip to distant hospitals or clinics for time-consuming testing with sputum” (11/7).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.